While much has been learned in the past year about decentralized and virtual trials, industry executives meeting last week at a SCOPE conference emphasized that virtual isn’t always the answer. Read More
The FDA’s Office of Good Clinical Practice responds to inquiries on a variety of trial-related subjects, providing answers on the agency’s official regulations as well as best practices. The following is a selection of questions and answers excerpted from the CenterWatch publication, GCP Questions, FDA Answers. Read More
Cancer trials have seen an evolution to more quickly deliver oncology therapies to patients, with researchers adopting the use of new endpoints in their trials, but further assessments of these endpoints are warranted due to conflicting opinions that persist among healthcare payers. Read More
Most COVID-19 trials fail to take gender into account in their design and data analysis despite the virus’s different effect on men and women, a new study reports. Read More
In a move to help clients ensure the quality and validity of their clinical trial results, WCG has purchased Intrinsic Imaging, a global provider of medical imaging core lab services. Read More
Thermo Fisher Scientific and the University of California, Davis have formed a collaboration to help clinical trial investigators conduct research in metabolomics, a growing field focused on the study of metabolites’ roles in the human body. Read More
